Vaxxinity has developed a novel platform that triggers a safe and specific antibody response against self-antigen, enabling the use of vaccines to treat chronic diseases. This webinar features advanced bioanalytical solutions for vaccine discovery and development from Sartorius, as well as a deep dive into Vaxxinity’s preclinical path to selecting vaccines, including a novel vaccine for Parkinson’s disease. Watch the On-Demand Webinar.
More efficient development of drugs with attractive side effect profiles requires robust, easy-to-use, cost-effective in vitro gut models that are physiologically representative of the human intestinal tract.
Critical quality attributes are fundamental to regulatory compliance in drug development and manufacturing. Learn how surface plasmon resonance has been applied for protein characterization of antibody effector function.
As we look forward to the future of drug development, a panel comprising industry consultants and early development experts discussed examining new short- and long-term CDMO and supply chain strategies.